Botanix Pharmaceuticals Limited (BXPHF)
OTCMKTS
· Delayed Price · Currency is USD
0.2900
0.00 (0.00%)
Jun 22, 2025, 8:00 PM EDT
Botanix Pharmaceuticals Revenue
Botanix Pharmaceuticals had revenue of 377.60K AUD in the half year ending December 31, 2024, a decrease of -89.83%. This brings the company's revenue in the last twelve months to 2.07M, up 373.26% year-over-year. In the fiscal year ending June 30, 2024, Botanix Pharmaceuticals had annual revenue of 2.07M, down -45.14%.
Revenue (ttm)
2.07M AUD
Revenue Growth
+373.26%
P/S Ratio
299.09
Revenue / Employee
188.10K AUD
Employees
11
Market Cap
382.98M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Botanix Pharmaceuticals News
- 2 months ago - Botanix Pharmaceuticals taps investors for $40m; Euroz, E&P in tow - The Australian Financial Review
- 5 months ago - This media company’s share price is tipped to double - The Australian Financial Review